LNAI - Enochian Biosciences Inc
0.3615
-0.020 -5.394%
Share volume: 91,821
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.38
-0.02
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 08-20-2024 | 01-07-2025 | 02-19-2025 | 02-19-2025 | 05-15-2025 | 11-14-2025 | 02-17-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 8.740 M | 5.433 M | 5.691 M | 4.514 M | 4.131 M | 2.435 M | 1.812 M | |
| Selling general and admin | 7.652 M | 4.999 M | 5.301 M | 4.353 M | 4.225 M | 2.411 M | 1.766 M | |
| Research and development | 1.087 M | 434.508 K | 390.189 K | 161.084 K | -94.073 K | 24.407 K | 45.872 K | |
| Total expenses | 51.381 M | 17.104 M | 53.339 M | 4.546 M | 4.162 M | 3.308 M | 1.823 M | |
| -66.71% | 211.84% | -91.48% | -8.44% | -20.52% | -44.88% | |||
| Operating income | -51.381 M | -17.104 M | -53.339 M | -4.546 M | -4.162 M | -3.308 M | -1.823 M | |
| Ebit | -50.911 M | -17.104 M | -44.089 M | -7.136 M | 377.789 K | 9.271 M | -1.683 M | |
| Pretax income | -51.214 M | -15.732 M | -44.212 M | -7.252 M | 189.176 K | 2.819 M | -1.799 M | |
| -69.28% | 181.04% | -83.60% | -102.61% | 1,390.16% | -163.83% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -51.214 M | -15.732 M | -44.212 M | -7.252 M | 189.176 K | 2.819 M | -1.799 M | |
| 69.28% | -181.04% | 83.60% | 102.61% | 1,390.16% | -163.83% |